The Center for Innovative Drug Discovery
provides capabilities and core services to support biomedical research related to drug discovery.
About the CIDD
The Center for Innovative Drug Discovery (CIDD), a joint venture between The University of Texas at San Antonio and UT Health San Antonio, is composed of two facilities: a High-Throughput Screening (HTS) Facility located at UT Health San Antonio and a Medicinal Chemistry and Synthesis Core Facility at UTSA.
The ultimate intent of the CIDD is to provide a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease.
The mission of the Center for Innovative Drug Discovery is to catalyze collaborations with investigators by providing high-quality, industry-level services and expertise related to small molecule drug discovery and pre-clinical development.